Takeda Pharmaceuticals: An Interesting Option For Income Investors

Takeda Pharmaceutical (NYSE: TAK ). They may not be as immediately recognizable to investors as some of the bigger western drug companies, but they are a substantial player in a number of drug sectors. If you've I'm Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared in Forbes, Toronto Star, Minneapolis Star-Tribune, Providence Journal, Washington Times and the Detroit Free Press, as well as American Conservative Magazine and the Quincy Institute for Responsible Sta ...